Recent functional analyses of genetically engineered mouse models further demonstrated that Epac1 deficiency resulted in reduced susceptibility to atrial fibrillation (the most common sustained cardiac arrhythmia) and ventricular arrhythmia [58]. Here, RAPGEF3 is linked to atrial fibrillation.